Approximately 5–10% of the cancer patient population harbour germline genetic alterations in cellular DNA repair genes associated with predisposition to malignancies [8, 9], of which BRCA1/2 are often reported and primarily associated with breast and ovarian cancers. Here, BRCA1 is linked to cancer.